Leo Pharma Strengthens Dermatology Position With Second Eczema Win

 
• By Alaric DeArment
  
Leo announced positive topline Phase III results for its topical JAK inhibitor in chronic hand eczema • Source: Shutterstock

More from Clinical Trials

More from R&D